Source: Annual Congress 2001 - Inflammatory mechanisms of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. L. M. Ricciardolo, A. Rossi, C. F. Donner, A. Di Stefano (Bergamo, Veruno, Italy). Nitrotyrosine immunostaining and cellular inflammation in COPD. Eur Respir J 2001; 16: Suppl. 31, 2114

Member's Comments

No comment yet.

Related content which might interest you: Increased nitrotyrosine immunoreactivity in bronchial biopsies from patients with severe COPD Source: Eur Respir J 2004; 24: Suppl. 48, 718s Year: 2004 Airway inflammation markers in COPD Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 The nature of inflammation and tissue damage in COPD Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD Year: 2004 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Measurement of in situ inflammatory cell activity in the lungs of patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Arginase in airway inflammation and remodelling Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Senescence marker protein-30 decreases oxidative stress in human lungs of smokers with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 Increased cytokeratin-19 expression in fibrotic interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 MiR-320d as a regulator of airway inflammation in COPD Source: ERS Lung Science Conference 2020 Year: 2020 Oxidative stress and redox regulation of lung inflammation in COPD Source: Eur Respir J 2006; 28: 219-242 Year: 2006 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006